News
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...
Hosted on MSN6d
Pregnant Woman Unable To Get COVID Vaccine Sues Robert F. Kennedy, Jr., "At Immediate Risk"MAGA supporters are voicing their opposition to the lawsuit on social media with claims that the plaintiffs suing Kennedy are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results